Abstract
Mesenchymal chondrosarcoma is very aggressive and represents approximately 1% of all chondrosarcomas. While it affects a very wide age range, the peak frequency is in the second decade of life. It may occur in the head and rib region with a predilection for the maxillofacial skeleton. The small cell undifferentiated component may assume a hemangiopericytoma-like vascular pattern and should be distinguished from hemangiopericytoma. Treatment is en bloc resection, the intended tissue margins of excision should be designed to extend well beyond the actual tumor margin, as mesenchymal chondrosarcomas. Aggressive behavior of mesenchymal chondrosarcoma of the jaw, with a tendency for delayed recurrence and metastasis even many years after treatment. The most frequent site of metastasis was the lung. Here we present 52 years old, female case of mesenchymal chondrosarcoma occurs on Rt. mandible.
References
1. Mu ¨ller S, So ¨der S, Oliveira AM, Inwards CY, Aigner T. Type II collagen as specific marker for mesenchymal chondrosarcomas compared to other small cell sarcomas of the skeleton. Mod Pathol. 2005; 18:1088–94.
2. Pellitteri PK, Ferlito A, Fagan JJ, Sua ′ rez C, Devaney KO, Rinaldo A. Mesenchymal chondrosarcoma of the head and neck. Oral Oncol. 2007; 43:970–5.
3. Aigner T, Loos S, Mu ¨ller S, Sandell LJ, Unni KK, Kirchner T. Cell differentiation and matrix gene expression in mesenchymal chondrosarcomas. Am J Pathol. 2000; 156:1327–35.
4. Aziz SR, Miremadi AR, McCabe JC. Mesenchymal chondrosarcoma of the maxilla with diffuse metastasis: case report and literature review. J Oral Maxillofac Surg. 2002; 60:931–5.
5. Crawford JG, Oda D, Egbert M, Myall R. Mesenchymal chondrosarcoma of the maxilla in a child. J Oral Maxillofac Surg. 1995; 53:938–41.
6. Zakkak TB, Flynn TR, Boguslaw B, Adamo AK. Mesenchymal chondrosarcoma of the mandible: case report and review of the literature. J Oral Maxillofac Surg. 1998; 56:84–91.
7. Dantonello TM, Int-Veen C, Leuschner I, Schuck A, Furtwaengler R, Claviez A, et al. Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults: experiences of the CWS and COSS study groups. Cancer. 2008; 112:2424–31.
8. Knott PD, Gannon FH, Thompson LD. Mesenchymal chondrosarcoma of the sinonasal tract: a clinicopathological study of 13 cases with a review of the literature. Laryngoscope. 2003; 113:783–90.
9. Christensen RE Jr. Mesenchymal chondrosarcoma of the jaws. Oral Surg Oral Med Oral Pathol. 1982; 54:197–206.
10. Ceylan A, Kagan Degerliyurt M, Celenk F, Atac¸ MS, Sabri Uslu S. Haemangiopericytoma of the hard palate. Dentomaxillofac Radiol. 2008; 37:58–61.
11. Gadwal SR, Fanburg-Smith JC, Gannon FH, Thompson LD. Primary chondrosarcoma of the head and neck in pediatric patients: a clinicopathologic study of 14 cases with a review of the literature. Cancer. 2000; 88:2181–8.
12. Dunfee BL, Sakai O, Pistey R, Gohel A. Radiologic and pathologic characteristics of benign and malignant lesions of the mandible. Radiographics. 2006; 26:1751–68.
13. Berk R, Heller A, Heller D, Schwartz S, Klein EA. Ewing's sarcoma of the mandible: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995; 79:159–62.
14. Folpe AL, Hill CE, Parham DM, O'Shea PA, Weiss SW. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor. Am J Surg Pathol. 2000; 24:1657–62.
15. Acioğlu E, Cansiz H, Mercan H, Dervis¸oğlu S. Head and neck hemangiopericytomas: diagnostic contradictions. J Craniofac Surg. 2009; 20:930–5.